Potential overtreatment in end-of-life care in adults 65 years or older dying from cancer: applying quality indicators on nationwide registries

References

• Shrestha A, Martin C, Burton M, et al. Quality of life versus length of life considerations in cancer patients: a systematic literature review. Psychooncology. 2019;28(7):1367–1380.
   PubMed Web of Science ®Google Scholar
• Cardona-Morrell M, Kim J, Turner RM, et al. Non-beneficial treatments in hospital at the end of life: a systematic review on extent of the problem. Int J Qual Health Care. 2016;28(4):456–469.
   PubMed Web of Science ®Google Scholar
• Chassin MR. Is health care ready for six sigma quality? Milbank Q. 1998;76(4):565–591, 510.
   PubMed Web of Science ®Google Scholar
• Institute of Medicine Committee on Quality of Health Care in A. Crossing the quality chasm: a new health system for the 21st century. Washington (DC): National Academies Press (US); 2001.
   Google Scholar
• DuMontier C, Loh KP, Bain PA, et al. Defining undertreatment and overtreatment in older adults with cancer: a scoping literature review. J Clin Oncol. 2020;38(22):2558–2569.
   PubMed Web of Science ®Google Scholar
• De Roo ML, Leemans K, Claessen SJ, EURO IMPACT, et al. Quality indicators for palliative care: update of a systematic review. J Pain Symptom Manage. 2013;46(4):556–572.
   PubMed Web of Science ®Google Scholar
• Henson LA, Edmonds P, Johnston A, et al. Population-based quality indicators for end-of-life cancer care: a systematic review. JAMA Oncol. 2020;6(1):142.
   PubMed Web of Science ®Google Scholar
• Teno JM, Gozalo PL, Bynum JP, et al. Change in end-of-life care for medicare beneficiaries: site of death, place of care, and health care transitions in 2000, 2005, and 2009. Jama. 2013;309(5):470–477.
   PubMed Web of Science ®Google Scholar
• Ho TH, Barbera L, Saskin R, et al. Trends in the aggressiveness of end-of-life cancer care in the universal health care system of Ontario, Canada. J Clin Oncol. 2011;29(12):1587–1591.
   PubMed Web of Science ®Google Scholar
• Earle CC, Landrum MB, Souza JM, et al. Aggressiveness of cancer care near the end of life: is it a quality-of-care issue? J Clin Oncol. 2008;26(23):3860–3866.
   PubMed Web of Science ®Google Scholar
• Fang P, Jagsi R, He W, et al. Rising and falling trends in the use of chemotherapy and targeted therapy near the end of life in older patients with cancer. J Clin Oncol. 2019;37(20):1721–1731.
   PubMedGoogle Scholar
• Rochigneux P, Raoul JL, Beaussant Y, et al. Use of chemotherapy near the end of life: what factors matter? Ann Oncol. 2017;28(4):809–817.
   PubMed Web of Science ®Google Scholar
• Kim YJ, Kim MJ, Cho YJ, et al. Who should be admitted to the intensive care unit? The outcome of intensive care unit admission in stage IIIB-IV lung cancer patients. Med Oncol. 2014;31(3):847.
   PubMed Web of Science ®Google Scholar
• Van den Block L, Pivodic L, Pardon K, et al. Transitions between health care settings in the final three months of life in four EU countries. Eur J Public Health. 2015;25(4):569–575.
   PubMed Web of Science ®Google Scholar
• Morin L, Todd A, Barclay S, et al. Preventive drugs in the last year of life of older adults with cancer: is there room for deprescribing? Cancer. 2019;125(13):2309–2317.
   PubMed Web of Science ®Google Scholar
• Frazier SC. Health outcomes and polypharmacy in elderly individuals: an integrated literature review. J Gerontol Nurs. 2005;31(9):4–11.
   PubMedGoogle Scholar
• De Schreye R, Houttekier D, Deliens L, et al. Developing indicators of appropriate and inappropriate end-of-life care in people with Alzheimer’s disease, cancer or chronic obstructive pulmonary disease for population-level administrative databases: a RAND/UCLA appropriateness study. Palliat Med. 2017;31(10):932–945.
   PubMed Web of Science ®Google Scholar
• De Schreye R, Smets T, Annemans L, et al. Applying quality indicators for administrative databases to evaluate end-of-life care for cancer patients in Belgium. Health Aff. 2017;36(7):1234–1243.
   Web of Science ®Google Scholar
• Regionala Cancercentrum i Samverkan. Nationellt vårdprogram palliativ vård. 2021. Available from: https://kunskapsbanken.cancercentrum.se/globalassets/vara-uppdrag/rehabilitering-palliativ-vard/vardprogram/nationellt-vardprogram-palliativ-vard.pdf
   Google Scholar
• Martinsson L, Heedman PA, Lundström S, et al. Improved data validity in the swedish register of palliative care. PLoS One. 2017;12(10):e0186804.
   PubMed Web of Science ®Google Scholar
• Bekelman JE, Halpern SD, Blankart CR, International Consortium for End-of-Life Research (ICELR), et al. Comparison of site of death, health care utilization, and hospital expenditures for patients dying with cancer in 7 developed countries. Jama. 2016;315(3):272–283.
   PubMed Web of Science ®Google Scholar
• Schneeweiss S, Avorn J. A review of uses of health care utilization databases for epidemiologic research on therapeutics. J Clin Epidemiol. 2005;58(4):323–337.
   PubMed Web of Science ®Google Scholar
• Mattsson TO, Pottegård A, Jørgensen TL, et al. End-of-life anticancer treatment – a nationwide registry-based study of trends in the use of chemo-, endocrine, immune-, and targeted therapies. Acta Oncol. 2021;60(8):961–967.
   PubMed Web of Science ®Google Scholar
• van Baal K, Schrader S, Schneider N, et al. Quality indicators for the evaluation of end-of-life care in Germany – a retrospective cross-sectional analysis of statutory health insurance data. BMC Palliat Care. 2020;19(1):187.
   PubMed Web of Science ®Google Scholar
• LeBlanc TW, Abernethy AP, Casarett DJ. What is different about patients with hematologic malignancies? A retrospective cohort study of cancer patients referred to a hospice research network. J Pain Symptom Manage. 2015;49(3):505–512.
   PubMed Web of Science ®Google Scholar
• Odejide OO, Salas Coronado DY, Watts CD, et al. End-of-life care for blood cancers: a series of focus groups with hematologic oncologists. J Oncol Pract. 2014;10(6):e396-403–e403.
   PubMedGoogle Scholar
• Halldén K. The Swedish educational system and classifying education using the ISCED‐97. The international standard classification of education (ISCED97). An evaluation of content and criterion validity for 15 European countries. Mannheim: university of Mannheim; 2008.
   Google Scholar
• Gilbert T, Neuburger J, Kraindler J, et al. Development and validation of a hospital frailty risk score focusing on older people in acute care settings using electronic hospital records: an observational study. Lancet. 2018;391(10132):1775–1782.
   PubMed Web of Science ®Google Scholar
• Seow H, Snyder CF, Mularski RA, et al. A framework for assessing quality indicators for cancer care at the end of life. J Pain Symptom Manage. 2009;38(6):903–912.
   PubMed Web of Science ®Google Scholar
• Claessen SJ, Francke AL, Belarbi HE, et al. A new set of quality indicators for palliative care: process and results of the development trajectory. J Pain Symptom Manage. 2011;42(2):169–182.
   PubMed Web of Science ®Google Scholar
• Mainz J. Defining and classifying clinical indicators for quality improvement. Int J Qual Health Care. 2003;15(6):523–530.
   PubMed Web of Science ®Google Scholar
• Donabedian A. The quality of care. How can it be assessed? Jama. 1988;260(12):1743–1748.
   PubMed Web of Science ®Google Scholar
• Hui D, Nooruddin Z, Didwaniya N, et al. Concepts and definitions for “actively dying,” “end of life,” “terminally ill,” “terminal care,” and “transition of care”: a systematic review. J Pain Symptom Manage. 2014;47(1):77–89.
   PubMed Web of Science ®Google Scholar
• Lindskog M, Tavelin B, Lundström S. Old age as risk indicator for poor end-of-life care quality – a population-based study of cancer deaths from the Swedish Register of Palliative Care. Eur J Cancer. 2015;51(10):1331–1339.
   PubMed Web of Science ®Google Scholar
• Earle CC, Neville BA, Landrum MB, et al. Evaluating claims-based indicators of the intensity of end-of-life cancer care. Int J Qual Health Care. 2005;17(6):505–509.
   PubMed Web of Science ®Google Scholar
• Earle CC, Park ER, Lai B, et al. Identifying potential indicators of the quality of end-of-life cancer care from administrative data. J Clin Oncol. 2003;21(6):1133–1138.
   PubMed Web of Science ®Google Scholar
• Grunfeld E, Lethbridge L, Dewar R, et al. Towards using administrative databases to measure population-based indicators of quality of end-of-life care: testing the methodology. Palliat Med. 2006;20(8):769–777.
   PubMed Web of Science ®Google Scholar
• Grunfeld E, Urquhart R, Mykhalovskiy E, et al. Toward population-based indicators of quality end-of-life care: testing stakeholder agreement. Cancer. 2008;112(10):2301–2308.
   PubMed Web of Science ®Google Scholar
• Barbera L, Seow H, Sutradhar R, et al. Quality of end-of-life cancer care in Canada: a retrospective four-province study using administrative health care data. Current Oncology. 2015;22(5):341–355.
   PubMed Web of Science ®Google Scholar
• Barbera L, Seow H, Sutradhar R, et al. Quality indicators of end-of-life care in patients with cancer: what rate is right? J Oncol Pract. 2015;11(3):e279-87–e287.
   PubMed Web of Science ®Google Scholar
• Krzyzanowska MK, Barbera L, Elit L, et al. Identifying population-level indicators to measure the quality of cancer care for women. Int J Qual Health Care. 2011;23(5):554–564.
   PubMed Web of Science ®Google Scholar
• Miyashita M, Morita T, Ichikawa T, et al. Quality indicators of end-of-life cancer care from the bereaved family members’ perspective in Japan. J Pain Symptom Manage. 2009;37(6):1019–1026.
   PubMed Web of Science ®Google Scholar
• Johnston G, Burge F. Analytic framework for clinician provision of end-of-life care. J Palliat Care. 2002;18(3):141–149.
   PubMed Web of Science ®Google Scholar
• Zerillo JA, Schouwenburg MG, van Bommel ACM, Colorectal Cancer Working Group of the International Consortium for Health Outcomes Measurement (ICHOM), et al. An international collaborative standardizing a comprehensive patient-centered outcomes measurement set for colorectal cancer. JAMA Oncol. 2017;3(5):686–694.
   PubMed Web of Science ®Google Scholar
• Morin L, Laroche ML, Vetrano DL, et al. Adequate, questionable, and inadequate drug prescribing for older adults at the end of life: a European expert consensus. Eur J Clin Pharmacol. 2018;74(10):1333–1342.
   PubMed Web of Science ®Google Scholar
• Lawrence M, Olesen F. Indicators of quality in health care. Eur J Gen Pract. 1997;3(3):103–108.
   Google Scholar
• Lane-Fall MB, Neuman MD. Outcomes measures and risk adjustment. Int Anesthesiol Clin. 2013;51(4):10–21.
   PubMedGoogle Scholar
• Nappa U, Lindqvist O, Rasmussen BH, et al. Palliative chemotherapy during the last month of life. Ann Oncol. 2011;22(11):2375–2380.
   PubMed Web of Science ®Google Scholar
• Szilcz M, Wastesson JW, Johnell K, et al. Unplanned hospitalisations in older people: illness trajectories in the last year of life. BMJ Support Palliat Care. 2021;bmjspcare-2020-002778.
   Web of Science ®Google Scholar
• Ludvigsson JF, Andersson E, Ekbom A, et al. External review and validation of the swedish national inpatient register. BMC Public Health. 2011;11(1):450.
   PubMed Web of Science ®Google Scholar
• Öhlén J, Cohen J, Håkanson C. Determinants in the place of death for people with different cancer types: a national population-based study. Acta Oncol. 2017;56(3):455–461.
   PubMed Web of Science ®Google Scholar
• Elmstedt S, Mogensen H, Hallmans DE, et al. Cancer patients hospitalised in the last week of life risk insufficient care quality – a population-based study from the Swedish register of palliative care. Acta Oncol. 2019;58(4):432–438.
   PubMed Web of Science ®Google Scholar
• Morin L, Wastesson JW, Laroche ML, et al. How many older adults receive drugs of questionable clinical benefit near the end of life? A cohort study. Palliat Med. 2019;33(8):1080–1090.
   PubMed Web of Science ®Google Scholar
• Wallerstedt SM, Wettermark B, Hoffmann M. The first decade with the Swedish prescribed drug register – a systematic review of the output in the scientific literature. Basic Clin Pharmacol Toxicol. 2016;119(5):464–469.
   PubMed Web of Science ®Google Scholar
• Wettermark B, Hammar N, Fored CM, et al. The new swedish prescribed drug register–opportunities for pharmacoepidemiological research and experience from the first six months. Pharmacoepidemiol Drug Saf. 2007;16(7):726–735.
   PubMed Web of Science ®Google Scholar
• Barlow L, Westergren K, Holmberg L, et al. The completeness of the Swedish Cancer Register: a sample survey for year 1998. Acta Oncol. 2009;48(1):27–33.
   PubMed Web of Science ®Google Scholar
• Beyea A, Winzelberg G, Stafford RE. To drain or not to drain: an evidence-based approach to palliative procedures for the management of malignant pleural effusions. J Pain Symptom Manage. 2012;44(2):301–306.
   PubMed Web of Science ®Google Scholar
• Bach PB, Schrag D, Begg CB. Resurrecting treatment histories of dead patients: a study design that should be laid to rest. Jama. 2004;292(22):2765–2770.
   PubMed Web of Science ®Google Scholar
• Glare P, Virik K, Jones M, et al. A systematic review of physicians’ survival predictions in terminally ill cancer patients. BMJ. 2003;327(7408):195–198.
   PubMed Web of Science ®Google Scholar
• Scott IA, Soon J, Elshaug AG, et al. Countering cognitive biases in minimising low value care. Med J Aust. 2017;206(9):407–411.
   PubMed Web of Science ®Google Scholar